{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:28:17Z","timestamp":1762640897556,"version":"3.30.2"},"reference-count":125,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2003,12,19]],"date-time":"2003-12-19T00:00:00Z","timestamp":1071792000000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bipolar Disorders"],"published-print":{"date-parts":[[2003,12]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold>Bipolar disorder is a complex condition that includes symptoms of mania, depression, and often anxiety. Diagnosing and treating bipolar depression is challenging, with the disorder often being diagnosed as unipolar depression. In addition, comorbid anxiety can be a significant detractor to successful outcomes, increasing symptom severity, frequency of episodes and suicide rates, and decreasing response to antidepressant therapy. Anxiety often precedes and hastens the onset of bipolar disorder, and a shared genetic etiology has been suggested. Studies have demonstrated the efficacy of atypical antipsychotics for the acute and maintenance treatment of mania. Evidence from studies in patients with treatment\u2010resistant major depressive disorder and bipolar depression indicate that these agents may also have antidepressant effects. In open trials in patients with bipolar mania, risperidone therapy has led to significant reductions in depression scores compared with baseline. Reductions in depression scores in patients with bipolar mania have been significantly greater with olanzapine compared with placebo. In patients with bipolar depression, the combination of olanzapine and fluoxetine resulted in significant improvement in depression compared with olanzapine alone or placebo. Although little data are available on the effects of these agents on comorbid anxiety in patients with bipolar disorder, some atypical antipsychotics have demonstrated efficacy in patients with anxiety disorders, including obsessive\u2010compulsive disorder, post\u2010traumatic stress disorder, and generalized anxiety disorder. Thus, atypical antipsychotics represent an important therapeutic option for the treatment of bipolar disorder, providing improvements in manic, depressive, and anxiety symptoms.<\/jats:p>","DOI":"10.1111\/j.1399-2406.2003.00061.x","type":"journal-article","created":{"date-parts":[[2003,12,19]],"date-time":"2003-12-19T09:08:22Z","timestamp":1071824902000},"page":"20-35","source":"Crossref","is-referenced-by-count":37,"title":["The role of atypical antipsychotics in bipolar depression and anxiety disorders"],"prefix":"10.1111","volume":"5","author":[{"given":"Roger","family":"McIntyre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Katzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,12,19]]},"reference":[{"key":"e_1_2_27_2_2","first-page":"29","article-title":"Evidence\u2010based long\u2010term treatment of bipolar II disorder","volume":"63","author":"Suppes T","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_27_3_2","first-page":"1","article-title":"Practice guideline for the treatment of patients with bipolar disorder (revision)","volume":"159","author":"American Psychiatric Association.","year":"2002","journal-title":"Am J Psychiatry"},{"key":"e_1_2_27_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(02)00324-5"},{"key":"e_1_2_27_5_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.52.3.358"},{"key":"e_1_2_27_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.9.844"},{"key":"e_1_2_27_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03540040037030"},{"key":"e_1_2_27_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(98)00142-6"},{"key":"e_1_2_27_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(02)00332-4"},{"key":"e_1_2_27_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(01)00413-X"},{"key":"e_1_2_27_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.56.10.889"},{"key":"e_1_2_27_12_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.173.1.11"},{"key":"e_1_2_27_13_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0206"},{"key":"e_1_2_27_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.6.530"},{"key":"e_1_2_27_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(98)00076-7"},{"key":"e_1_2_27_16_2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/070674370204700420","article-title":"The Mood Disorder Questionnaire for assessing bipolar spectrum disorder frequency","volume":"47","author":"Benazzi F.","year":"2002","journal-title":"Can J Psychiatry"},{"key":"e_1_2_27_17_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0111"},{"key":"e_1_2_27_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(94)90104-X"},{"key":"e_1_2_27_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-440X(97)90089-4"},{"key":"e_1_2_27_20_2","doi-asserted-by":"publisher","DOI":"10.1177\/070674370204700202"},{"key":"e_1_2_27_21_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.150.10.1548"},{"key":"e_1_2_27_22_2","first-page":"1","volume-title":"Comorbidity in Affective Disorders","author":"Kessler R.","year":"1999"},{"key":"e_1_2_27_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-440X(95)90080-F"},{"key":"e_1_2_27_24_2","first-page":"613","article-title":"Sources of lithium resistance in mixed mania","volume":"22","author":"Himmelhoch J","year":"1986","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_27_25_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n1207"},{"key":"e_1_2_27_26_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.6.956"},{"issue":"1","key":"e_1_2_27_27_2","doi-asserted-by":"crossref","first-page":"77S","DOI":"10.1177\/070674372001460101007","article-title":"Clinical guidelines for the treatment of depressive disorders. VII Comorbidity","volume":"46","author":"Enns M","year":"2001","journal-title":"Can J Psychiatry"},{"key":"e_1_2_27_28_2","doi-asserted-by":"publisher","DOI":"10.1159\/000063824"},{"key":"e_1_2_27_29_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.3.420"},{"key":"e_1_2_27_30_2","doi-asserted-by":"publisher","DOI":"10.1053\/comp.2002.33500"},{"key":"e_1_2_27_31_2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1176\/ajp.156.3.474","article-title":"Multiple anxiety disorder comorbidity in patients with mood spectrum disorders with psychotic features","volume":"156","author":"Cassano G","year":"1999","journal-title":"Am J Psychiatry"},{"key":"e_1_2_27_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(93)90118-4"},{"key":"e_1_2_27_33_2","doi-asserted-by":"publisher","DOI":"10.1053\/comp.2000.9011"},{"key":"e_1_2_27_34_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.10.1679"},{"key":"e_1_2_27_35_2","doi-asserted-by":"publisher","DOI":"10.1089\/104454602760219144"},{"key":"e_1_2_27_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(95)02752-1"},{"key":"e_1_2_27_37_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.1.30"},{"key":"e_1_2_27_38_2","first-page":"829","article-title":"Bipolar disorder and panic disorder in families: an analysis of chromosome 18 data","volume":"155","author":"MacKinnon D","year":"1998","journal-title":"Am J Psychiatry"},{"key":"e_1_2_27_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(00)00299-8"},{"key":"e_1_2_27_40_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n0514"},{"key":"e_1_2_27_41_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03450190043026"},{"key":"e_1_2_27_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800350011002"},{"key":"e_1_2_27_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199202001-00004"},{"key":"e_1_2_27_44_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.12.2048"},{"key":"e_1_2_27_45_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n1103"},{"key":"e_1_2_27_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0193-953X(05)70098-8"},{"issue":"2","key":"e_1_2_27_47_2","first-page":"63","article-title":"Suicide attempts in major affective disorder patients with comorbid substance use disorders","volume":"60","author":"Tondo L","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_27_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050562"},{"key":"e_1_2_27_49_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2001.00464.x"},{"key":"e_1_2_27_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2001.tb05796.x"},{"issue":"9","key":"e_1_2_27_51_2","first-page":"35","article-title":"Efficacy of lithium in mania and maintenance therapy of bipolar disorder","volume":"61","author":"Bowden C.","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_27_52_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.5.481"},{"key":"e_1_2_27_53_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v58n1102"},{"key":"e_1_2_27_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/0924-977X(96)00029-6"},{"key":"e_1_2_27_55_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0203"},{"key":"e_1_2_27_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(00)00980-X"},{"key":"e_1_2_27_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(02)80202-4"},{"key":"e_1_2_27_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(01)00435-9"},{"key":"e_1_2_27_59_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n1011"},{"key":"e_1_2_27_60_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.182.2.141"},{"key":"e_1_2_27_61_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200110000-00002"},{"key":"e_1_2_27_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(02)80293-0"},{"key":"e_1_2_27_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(02)80201-2"},{"key":"e_1_2_27_64_2","unstructured":"KeckP CoryaS CaseM TohenM.Analysis of treatment\u2010emergent mania with olanzapine\/fluoxetine combination [Abstract NR475]. Presented at 156th APA Annual Meeting San Francisco CA May 17\u201322 2003."},{"key":"e_1_2_27_65_2","unstructured":"TohenM VietaE CalabreseJet al.Olanzapine\/fluoxetine combination and olanzapine in the treatment of bipolar depression [Abstract 16]. Presented at 156th APA Annual Meeting San Francisco CA May 17\u201322 2003."},{"key":"e_1_2_27_66_2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","article-title":"Olanzapine versus placebo in the treatment of acute mania. The Olanzapine HGEH Study Group","volume":"156","author":"Tohen M","year":"1999","journal-title":"Am J Psychiatry"},{"key":"e_1_2_27_67_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.9.841"},{"key":"e_1_2_27_68_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.6.1011"},{"key":"e_1_2_27_69_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.1.62"},{"issue":"1","key":"e_1_2_27_70_2","article-title":"Antidepressant efficacy and tolerability of risperidone and olanzapine in bipolar disorder [Poster P. 2 E 066]","volume":"5","author":"McIntyre R","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"e_1_2_27_71_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.1.112"},{"key":"e_1_2_27_72_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n0307"},{"key":"e_1_2_27_73_2","unstructured":"JonesM HuizarK.Quetiapine monotherapy for acute mania associated with bipolar disorder (STAMP 1 and STAMP 2) [Abstract]. Presented at 156th APA Annual Meeting San Francisco CA May 17\u201322 2003."},{"key":"e_1_2_27_74_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n07a04"},{"key":"e_1_2_27_75_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145702002857"},{"key":"e_1_2_27_76_2","doi-asserted-by":"publisher","DOI":"10.1002\/da.10045"},{"key":"e_1_2_27_77_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n1005"},{"key":"e_1_2_27_78_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005183422001"},{"key":"e_1_2_27_79_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0510"},{"key":"e_1_2_27_80_2","doi-asserted-by":"publisher","DOI":"10.1002\/1520-6394(2001)13:1<18::AID-DA3>3.0.CO;2-M"},{"key":"e_1_2_27_81_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199911000-00002"},{"key":"e_1_2_27_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(98)00164-9"},{"key":"e_1_2_27_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(98)00093-6"},{"key":"e_1_2_27_84_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200015060-00005"},{"key":"e_1_2_27_85_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200008002-00006"},{"key":"e_1_2_27_86_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n1105"},{"key":"e_1_2_27_87_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.5.485"},{"key":"e_1_2_27_88_2","doi-asserted-by":"publisher","DOI":"10.1002\/1520-6394(2000)11:4<187::AID-DA9>3.0.CO;2-C"},{"key":"e_1_2_27_89_2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/milmed\/164.8.605","article-title":"Risperidone as an adjunct therapy for post\u2010traumatic stress disorder","volume":"164","author":"Krashin D","year":"1999","journal-title":"Mil Med"},{"volume-title":"Syllabus and Scientific Proceedings in Summary Form, Annual Meeting of the American Psychiatric Association.","year":"2002","author":"David D","key":"e_1_2_27_90_2"},{"key":"e_1_2_27_91_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200301000-00001"},{"issue":"1","key":"e_1_2_27_92_2","first-page":"130","article-title":"Risperidone in the treatment of chronic combat\u2010related post traumatic stress disorder [Abstract P. 2 W 056]","volume":"5","author":"Bartzokis G","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"e_1_2_27_93_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200304000-00012"},{"key":"e_1_2_27_94_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200111000-00003"},{"key":"e_1_2_27_95_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200107000-00003"},{"key":"e_1_2_27_96_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.10.1777"},{"issue":"1","key":"e_1_2_27_97_2","article-title":"Olanzapine or fluphenazine in patients with psychotic combat\u2010related posttraumatic stress disorder [Poster P. 2 W 050]","volume":"5","author":"Kozaric\u2010Kovacic D","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"e_1_2_27_98_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200302000-00003"},{"key":"e_1_2_27_99_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200206000-00012"},{"key":"e_1_2_27_100_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950040046006"},{"key":"e_1_2_27_101_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0203"},{"key":"e_1_2_27_102_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v58n0306"},{"key":"e_1_2_27_103_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.8.794"},{"key":"e_1_2_27_104_2","first-page":"51","article-title":"Risperidone as adjunctive treatment for SSRI\u2010refractory obsessive\u2010compulsive disorder [Abstract 151]","volume":"51","author":"Li X","year":"2002","journal-title":"Biol Psychiatry"},{"key":"e_1_2_27_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(02)80534-X"},{"key":"e_1_2_27_106_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200015050-00007"},{"key":"e_1_2_27_107_2","unstructured":"BuchsbaumM HollanderE PallantiS Baldini\u2010RossiN PlatholiJ SoodE.Positron emission tomography Imaging of risperidone augmentation in SRI\u2010refractory patients [Abstract]. Paper Presented At. Anxiety Disorders Association of America March 27\u201330 2003 Toronto Canada."},{"key":"e_1_2_27_108_2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/070674370104600408","article-title":"Olanzapine augmentation of serotonin uptake inhibitors in obsessive\u2010compulsive disorder: an open study","volume":"46","author":"Francobandiera G.","year":"2001","journal-title":"Can J Psychiatry"},{"key":"e_1_2_27_109_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n0709"},{"key":"e_1_2_27_110_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0804"},{"key":"e_1_2_27_111_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(02)80570-3"},{"key":"e_1_2_27_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1781(00)00203-1"},{"key":"e_1_2_27_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(03)00050-2"},{"key":"e_1_2_27_114_2","unstructured":"DenysD Van MegenH WestenbergH.A double\u2010blind placebo\u2010controlled study of quetiapine addition in treatment refractory patients with OCD [Abstract NR770]. Presented at 156th APA Annual Meeting San Francisco CA May 17\u201322 2003."},{"key":"e_1_2_27_115_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200205000-00004"},{"key":"e_1_2_27_116_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0807"},{"key":"e_1_2_27_117_2","first-page":"23","article-title":"Antipsychotic augmentation for treatment resistant obsessive\u2010compulsive disorder: what if antipsychotic is discontinued?","volume":"18","author":"Maina G","year":"2003","journal-title":"Int Clin Psychopharmacol"},{"key":"e_1_2_27_118_2","first-page":"15","article-title":"Obsessive\u2010compulsive disorder in schizophrenia: epidemiologic and biologic overlap","volume":"24","author":"Tibbo P","year":"1999","journal-title":"J Psychiatry Neurosci"},{"key":"e_1_2_27_119_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0603"},{"key":"e_1_2_27_120_2","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1176\/ajp.155.6.855","article-title":"Worsening of obsessive\u2010compulsive symptoms following treatment with olanzapine","volume":"155","author":"Morrison D","year":"1998","journal-title":"Am J Psychiatry"},{"key":"e_1_2_27_121_2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1176\/ajp.156.5.799","article-title":"Olanzapine\u2010induced obsessive\u2010compulsive disorder","volume":"156","author":"Mottard J","year":"1999","journal-title":"Am J Psychiatry"},{"key":"e_1_2_27_122_2","first-page":"55","article-title":"Quetiapine and obsessive\u2010compulsive symptoms (OCS): case report and review of atypical antipsychotic\u2010induced OCS","volume":"26","author":"Khullar A","year":"2001","journal-title":"J Psychiatry Neurosci"},{"key":"e_1_2_27_123_2","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1176\/ajp.156.12.1998","article-title":"Obsessive\u2010compulsive disorder in patients with first\u2010episode schizophrenia","volume":"156","author":"Poyurovsky M","year":"1999","journal-title":"Am J Psychiatry"},{"key":"e_1_2_27_124_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-8360"},{"key":"e_1_2_27_125_2","unstructured":"Brawman\u2010MintzerO.Adjunctive risperidone for treatment resistant general anxiety disorders patients. Facing unmet needs. atypical antipsychotics for mood and anxiety [oral presentation]. Presented at a Satellite Symposium at 156th APA Annual Meeting San Francisco CA May 17\u201322 2003."},{"issue":"1","key":"e_1_2_27_126_2","article-title":"Adjunctive olanzapine for treatment refractory generalized anxiety disorder: an interim analysis [Poster P. 4 W 056]","volume":"5","author":"Kinrys G","year":"2002","journal-title":"Int J Neuropsychopharmacol"}],"container-title":["Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-2406.2003.00061.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-2406.2003.00061.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T17:57:01Z","timestamp":1734199021000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-2406.2003.00061.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":125,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["10.1111\/j.1399-2406.2003.00061.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-2406.2003.00061.x","archive":["Portico"],"relation":{},"ISSN":["1398-5647","1399-5618"],"issn-type":[{"type":"print","value":"1398-5647"},{"type":"electronic","value":"1399-5618"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}